These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9578169)

  • 21. Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high-followed by low-dosage regimen.
    Malet F; Colin J; Jauch A; Abalain ML
    Ophthalmic Res; 1995; 27(6):322-9. PubMed ID: 8927304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulations.
    Zelenitsky S; Ariano R; Harding G; Forrest A
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4009-14. PubMed ID: 16189073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
    Jang CH; Park SY
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolones clinafloxacin and PD 131628 and nine other antimicrobial agents.
    Ford AS; Baltch AL; Smith RP; Ritz W
    J Antimicrob Chemother; 1993 Apr; 31(4):523-32. PubMed ID: 8390434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of fluoroquinolones studied on a model of suppurative meningoencephalitis caused by Pseudomonas aeruginosa in mice].
    Padeĭskaia EN; Mnatsakanian VE
    Antibiot Khimioter; 1991 Jul; 36(7):25-8. PubMed ID: 1953184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of experimental splenic autotransplantation and imipenem-cilastatin treatment in postsplenectomy Pseudomonas aeruginosa sepsis.
    Eskitürk A; Söyletir G; Peker O; Haklar G; Yalçin AS; Demirel M; Işgör A
    Res Exp Med (Berl); 1995; 195(3):163-9. PubMed ID: 8570911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current therapeutical management, new antibiotics and treatment of Pseudomonas aeruginosa in bacterial ENT-infections].
    Elies W
    Laryngorhinootologie; 2002 Jan; 81(1):40-5. PubMed ID: 11845401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoroquinolone pharmacodynamics: prospective determination of relationships between exposure and outcome.
    Drusano GL
    J Chemother; 2000 Oct; 12 Suppl 4():21-6. PubMed ID: 11131956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.
    Highet VS; Forrest A; Ballow CH; Schentag JJ
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():55-63. PubMed ID: 10225573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Blomquist IK; Kim KS
    J Antimicrob Chemother; 1986 May; 17(5):641-9. PubMed ID: 2941403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal allograft abscesses following transplant: case report and literature review.
    Shoja MM; Ardalan MR; Etemadi J; Tubbs RS; Varshochi M
    Exp Clin Transplant; 2007 Dec; 5(2):720-3. PubMed ID: 18194131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.
    Oishi K; Sonoda F; Iwagaki A; Kobayashi S; Nagatake T; Matsumoto K
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1352-7. PubMed ID: 1324643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa in chronic suppurative otitis media: sensitivity spectrum against various antibiotics in Karachi.
    Mansoor T; Musani MA; Khalid G; Kamal M
    J Ayub Med Coll Abbottabad; 2009; 21(2):120-3. PubMed ID: 20524487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.
    Hyatt JM; Schentag JJ
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S9-11. PubMed ID: 10654629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.